The intronic rs11465804 located at IL23R, with an unclear functional impact, has been previously associated with susceptibility to AS, but a reduced risk for IBD as well as a lower response to infliximab in contrast to the CC genotype for IBD [166,167]. Here, IL23R is linked to inflammatory bowel disease.